Showing results (331-340 of 348) with videos related to

Sort By:
Pageof 35
Leukemia|August 22, 2015
Targeting IL-17A in multiple myeloma: a potential novel therapeutic approach in myelomaR H Prabhala, M Fulciniti, D Pelluru, et al.
Leukemia|April 17, 2013
CRM1 inhibition induces tumor cell cytotoxicity and impairs osteoclastogenesis in multiple myeloma: molecular mechanisms and therapeutic implicationsY-T Tai, Y Landesman, C Acharya, et al.
Mabs|December 2, 2025
A high-throughput platform for biophysical antibody developability assessment to enable AI/ML model trainingAmmar Arsiwala, Rebecca Bhatt, Lood van Niekerk, et al.
Leukemia|April 23, 2010
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and managementR A Kyle, B G M Durie, S V Rajkumar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 11, 2020
Management of early melanoma recurrence despite adjuvant anti-PD-1 antibody therapy☆C N Owen, A N Shoushtari, D Chauhan, et al.
Seminars in Hematology|April 26, 2023
Report of consensus panel 7 from the 11th international workshop on Waldenström macroglobulinemia on priorities for novel clinical trialsC S Tam, P Kapoor, J J Castillo, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 20, 2016
Second primary malignancies in multiple myeloma: an overview and IMWG consensusP Musto, K C Anderson, M Attal, et al.
Leukemia|December 21, 2007
Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaA Palumbo, S V Rajkumar, M A Dimopoulos, et al.
Leukemia|June 5, 2009
International Myeloma Working Group guidelines for the management of multiple myeloma patients ineligible for standard high-dose chemotherapy with autologous stem cell transplantationA Palumbo, O Sezer, R Kyle, et al.
Leukemia|November 21, 2013
New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG)E M Ocio, P G Richardson, S V Rajkumar, et al.
Pageof 35